Boston officials herald big Genzyme expansion

Genzyme broke ground today on a $150 million expansion on its manufacturing facility on the Charles River in Boston. The expansion will add 90 new workers to the 400 already employed at the plant. Local economic development groups have heralded the new project. The Boston Redevelopment Authority launched a new effort a few years ago to create 10,000 new life science jobs in the area by 2010. And they say that Genzyme's project will help them meet that goal. One wonders how they're doing the exact head count. Philadelphia threw a bunch of healthcare workers into its biotech pot when counting jobs a few years ago. These figures can be very creative.

- see Genzyme's release
- read the report from The Boston Globe

Related Articles:
Top Five Regions Targeting Biotech Companies--2007. Special Report
AstraZeneca to outsource manufacturing. Report
Boston biotech booming as scientific research flourishes. Report
Manufacturing woes plague launch of Myozyme. Report

Suggested Articles

After delivering a "positive surprise" in December, Biogen is painting a fuller picture of its lupus drug.

A new CRISPR technique neutralizes SARS-CoV-2 by scrambling the virus' genetic code. It could prove useful for fighting other viruses, like influenza.

The deal, which follows a bidding war with AcelRx, gives Melinta another approved antibiotic and potentially complementary R&D expertise.